Valuation: E for L Aim

Market Cap 520M 15.44M 13.56M 12.62M 11.58M 21.75M 1.49B 22.09M 150M 58.53M 731M 57.98M 56.73M 2.53B P/E 2024
54.8x
P/E 2025 13.5x
Enterprise Value 799M 23.73M 20.84M 19.38M 17.78M 33.42M 2.28B 33.93M 230M 89.91M 1.12B 89.07M 87.15M 3.88B EV / Sales 2024
1.02x
EV / Sales 2025 0.67x
Free-Float
58.92%
Yield 2024 *
-
Yield 2025 -
05-14 E for L Aim Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-03 E for L Aim Public Company Limited Announces Extension of Principal Repayment Period Considered A Significant Transaction CI
03-11 E for L Aim Public Company Limited Announces Chief Financial Officer Changes, Effective February 1, 2026 CI
02-27 E for L Aim Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-02 E for L Aim appoints Preecha Nuntnarumit as acting chief financial officer RE
02-02 E for L Aim Public Company Limited Announces Change in Chief Financial Officer, Effective from February 1, 2026 CI
11-13 E for L Aim Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-14 E for L Aim Public Company Limited Appoints Thanadech Mahapokai as Independent Director, Chairman of the Audit Committee and Member of the NRC, Member of the RM Subcommittee, Effective August 14, 2025 CI
25-08-14 E for L Aim Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-01 E for L Aim Public Company Limited Announces Resignation of Watcharaporn Suwinchai as Director, Effective July 31, 2025 CI
25-05-21 E for L Aim Public Company Limited Disapprove the Re-Election of Rujapong Prabhasanobol as Independent Director, Chairperson of the Audit Committee, Member of the Nomination and Remuneration Committee and Member of the Risk Subcommittee CI
25-05-15 E for L Aim Public Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2025 CI
25-02-27 E for L Aim Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
6 months-7.14%
Current year-13.33%
1 week 0.11
Extreme 0.11
0.13
1 month 0.11
Extreme 0.11
0.13
Current year 0.11
Extreme 0.11
0.17
1 year 0.11
Extreme 0.11
0.2
3 years 0.07
Extreme 0.07
0.41
5 years 0.07
Extreme 0.07
2.8
10 years 0.07
Extreme 0.07
4.8
Manager TitleAgeSince
Chief Executive Officer 68 2018-05-14
Director of Finance/CFO - 2018-12-31
Director TitleAgeSince
Director/Board Member 67 2025-08-13
Chairman - 2021-07-31
Chairman 68 2013-11-30
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-7.14%-13.33% 15.44M
+1.55%-0.36%-18.24%-31.59% 181M
-0.37%+0.93%-41.74%-56.35% 164M
0.00%+1.28%-33.37%-1.40% 52.63M
Average +0.30%+3.02%-25.12%-25.67% 103.19M
Weighted average by Cap. +0.53%+1.13%-29.09%-36.89%

Financials

2024 2025
Net sales 1.34B 39.81M 34.97M 32.52M 29.84M 56.07M 3.83B 56.94M 386M 151M 1.89B 149M 146M 6.52B 1.31B 38.79M 34.07M 31.68M 29.08M 54.63M 3.74B 55.47M 376M 147M 1.84B 146M 142M 6.35B
Net income 19.69M 585K 514K 478K 439K 824K 56.35M 837K 5.68M 2.22M 27.7M 2.2M 2.15M 95.78M 44.57M 1.32M 1.16M 1.08M 993K 1.87M 128M 1.89M 12.85M 5.02M 62.7M 4.97M 4.86M 217M
Net Debt 290M 8.62M 7.57M 7.04M 6.46M 12.14M 830M 12.33M 83.64M 32.68M 408M 32.37M 31.68M 1.41B 279M 8.28M 7.27M 6.77M 6.21M 11.66M 798M 11.84M 80.34M 31.39M 392M 31.09M 30.42M 1.36B
Logo E for L Aim
E for L Aim Public Company Limited is a Thailand-based company engaged in the distribution of medical devices and equipment. The Company is principally engaged in one operating segment, which is the distribution of medical devices and equipment and providing service of medical equipment. Its medical devices and equipment include products for disinfection and sterilization, critical care and emergency, anesthesiology, medical innovation and informatics, health recovery, dialysis systems, and others. Its diagnostic products and laboratory reagents include clinical chemistry testing products, hematology testing products, immunology testing products, microbiology testing products, blood banking products, laboratory information systems (LIS), and others. The Company’s subsidiary, Spacemed Co., Ltd., is engaged in the sale of medical equipment and research instruments such as microscopes, automatic arm-in blood pressure monitors, weighing scales, nebulizers, suction machines, and others.
Employees
3,058
Date Price Change Volume
26-07-24 THB 0.1300 0.00% 852,810
26-07-23 THB 0.1300 +8.33% 735,543
26-07-22 THB 0.1200 0.00% 660,417
26-07-21 THB 0.1200 0.00% 1,272,225
26-07-20 THB 0.1200 -7.69% 2,630,538
  1. Stock Market
  2. Stocks
  3. EFORL Stock